Cimzia® (Certolizumab Pegol) Data Showed Rapid Improvement In Rheumatoid Arthritis Patients
Links shared publicly online about this topic.
- 319total visits
Cimzia® (Certolizumab Pegol) Data Showed Rapid Improvement In Rheumatoid Arthritis Patients
View full resource at medicalnewstoday.com
Tags: Crohn's Disease Medication, Arthritis, Rheumatoid Arthritis, Cimzia, UCB, Rheumatology
Most Recently Shared on May 3, 2011 at 8:00 pm By:
Cimzia® (Certolizumab Pegol) Data Showed Rapid Improvement In Rheumatoid Arthritis Patients: UCB announced today... http://bit.ly/lDFv4Y
Cimzia Trial Shows Promise For Axial Spondyloarthritis And Ankylosing Spondylitis
medicalnewstoday.com — “According to UCB, certolizumab pegol achieved top-level results in a phase 3 study, which assessed the drug's efficacy and safety in patients with adult-onset active axial spondyloarthr” View full resource at medicalnewstoday.com
Most Recently Shared on April 17, 2012 at 5:05 pm By:
Cimzia Trial Shows Promise For Axial Spondyloarthritis And Ankylosing Spondylitis http://t.co/o6piItx0 #healthnews
UCB initiates EXXELERATE study in rheumatoid arthritis
news-medical.net — “UCB today announced the start of the EXXELERATE study which will evaluate the short- and long-term efficacy of Cimzia (certolizumab pegol) plus methotrexate (MTX) compared with that of Humira(adalimumab) plus MTX in the treatment of moderate to severe rheumatoid arthritis (RA). The start of this study confirms previously announced plans.” View full resource at news-medical.net
Most Recently Shared on December 21, 2011 at 9:03 am By:
UCB initiates EXXELERATE study in rheumatoid arthritis: UCB today announced the start of the EXXELERATE study wh... http://t.co/KFUBIegg
UCB Announces Start of the EXXELERATE™ Clinical Study in Rheumatoid Arthritis - Yahoo! Finance
finance.yahoo.com — “From Yahoo! Finance: BRUSSELS , Dec. 21, 2011 /PRNewswire/ -- UCB today announced the start of the EXXELERATE™ study which will evaluate the short- and long-term efficacy of Cimzia® (certolizumab pegol) plus methotrexate (MTX) ...” View full resource at finance.yahoo.com
Most Recently Shared on December 21, 2011 at 8:16 am By:
UCB Announces Start of the EXXELERATE™ Clinical Study in Rheumatoid Arthritis: BRUSSELS , Dec. 21, 2011 /PRNewsw... http://t.co/vRxR53lC
New Cimzia (cerolizumab Pegol) Data From RAPID 1, REALISTIC, And Japanese Phase III Trials At ACR
medicalnewstoday.com — “UCB, the Belgian bio-pharma company has fielded more data on Cimzia (certolizumab pegol) its pegylated biologic treatment that inhibits tumour necrosis factor (TNF), this time during the American” View full resource at medicalnewstoday.com
Most Recently Shared on November 11, 2011 at 2:05 pm By:
New Cimzia (cerolizumab Pegol) Data From RAPID 1, REALISTIC, And Japanese Phase III Trials At ACR http://t.co/HE3Xe7TO #healthnews
Tumor Necrosis Factor-alpha (TNF?) Blockers: Label Change - Boxed Warning Updated for Risk of Infection from Legionella and Listeria - Drugs.com MedNews
drugs.com — “including Remicade (infliximab), Enbrel (etanercept), Humira (adalimumab), Cimzia (certolizumab pegol), and Simponi (golimumab) AUDIENCE Rheumatology, Gastroent” View full resource at drugs.com
Most Recently Shared on September 8, 2011 at 2:14 pm By:
Drugs and Devices OW OW Health
Tumor Necrosis Factor-alpha (TNF?) Blockers: Label Change - Boxed Warning Updated for Risk of Infection fr... http://t.co/ywMmIfA #drug
Press - News - 504 - Research Study Announcement: Certolizumab Pegol in Subjects With Active Axial Spondyloarthritis
spondylitis.org — “Ankylosing spondylitis and related disease information. Ankylosing spondylitis symptoms, diagnosis, treatment, medication, educational materials, brochures. Spondylitis patient support, message boards, physician resources and more. SAA is a non-profit organization and we were the first and remain the largest resource for people affected by spondylitis in the United States.” View full resource at spondylitis.org
Most Recently Shared on June 15, 2011 at 9:01 pm By:
Spondylitis.org Health Organization
Phase 3 Clinical Trial with biologic drug, certolizumab pegol (Cimzia) for #Spondylitis patients http://t.co/Fyr47rS Now recruiting. #rheum
Phase 3b Study of Cimzia for Rheumatoid Arthritis - ONA
oncologynurseadvisor.com — “UCB Inc. announced additional data from its subgroup analysis of REALISTIC Phase 3b study of Cimzia (certolizumab pegol) for the treatment of rheumatoid arthritis (RA).” View full resource at oncologynurseadvisor.com
Most Recently Shared on May 31, 2011 at 6:05 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Phase 3b Study of Cimzia for Rheumatoid Arthritis http://goo.gl/fb/kdi0h
Phase 3b Study of Cimzia for Rheumatoid Arthritis - MPR
empr.com — “UCB Inc. announced additional data from its subgroup analysis of REALISTIC Phase 3b study of Cimzia (certolizumab pegol) for the treatment of rheumatoid arthritis (RA).” View full resource at empr.com
Most Recently Shared on May 31, 2011 at 3:18 pm By:
MPR News: Phase 3b Study of Cimzia for Rheumatoid Arthritis: UCB Inc. announced additional data from its subgrou... http://bit.ly/jEgQCq
New Data for Cimzia (Certolizumab Pegol) Showed a Rapid Clinical Response Across a Broad Population of Rheumatoid Arthritis (RA) Patients - Drugs.com MedNews
drugs.com — “REALISTIC Phase IIIb clinical trial, showed rapid and consistent improvements across a broad population of patients taking Cimzia whether they had previously re” View full resource at drugs.com
Most Recently Shared on May 27, 2011 at 8:11 pm By:
Drugs and Devices OW OW Health
New Data for Cimzia (Certolizumab Pegol) Showed a Rapid Clinical Response Across a Broad Population of Rhe... http://bit.ly/j2u0jb #drug
UCB to test Cimzia in head-to-head study versus Abbott's Humira | FirstWord Pharma
firstwordpharma.com — “FirstWord Pharma - Gain Access to the Information You Need Track the Companies, Products, and Regulatory Areas of Most Interest to You” View full resource at firstwordpharma.com
Most Recently Shared on May 25, 2011 at 11:16 am By:
RT @fwpharma: UCB to test Cimzia in head-to-head study versus Abbott's Humira. http://bit.ly/k5ozlI
UCB To Conduct First Anti-TNF Head-to-head Study Between Cimzia(R) (certolizumab Pegol) And Humira(R)* (adalimumab)
medicalnewstoday.com — “UCB today announced its plan to launch the first industry sponsored anti-TNF head-to-head study that will assess the effectiveness of Cimzia® (certolizumab pegol) and Humira® (adalimumab)” View full resource at medicalnewstoday.com
Most Recently Shared on May 25, 2011 at 10:01 am By:
UCB To Conduct First Anti-TNF Head-to-head Study Between Cimzia(R) (certolizumab Pegol) And Humira(R)* (adalimum... http://bit.ly/kTlgoC
UCB To Conduct First Anti-TNF Head-to-head Study Between Cimzia(R) (certolizumab Pegol) And Humira(R)* (adalimumab)
medicalnewstoday.com — “UCB today announced its plan to launch the first industry sponsored anti-TNF head-to-head study that will assess the effectiveness of Cimzia® (certolizumab pegol) and Humira® (adalimumab)” View full resource at medicalnewstoday.com
Most Recently Shared on May 25, 2011 at 9:05 am By:
MNT Arthritis News Health News
UCB To Conduct First Anti-TNF Head-to-head Study Between Cimzia(R) (certolizumab Pegol) And Humira(R)* (adalimumab) http://mnt.to/3Wj8
Novel ACR Hybrid Score in Rheumatoid Arthritis Applied for the First Time to Data from the RAPID 1 Study with Cimzia (certolizumab pegol) - Drugs.com MedNews
drugs.com — “- American College of Rheumatology (ACR) hybrid score associated with greater sensitivity for measuring treatment response in rheumatoid arthritis (RA) compared” View full resource at drugs.com
Most Recently Shared on May 16, 2011 at 6:12 pm By:
Drugs and Devices OW OW Health
Novel ACR Hybrid Score in Rheumatoid Arthritis Applied for the First Time to Data from the RAPID 1 Study w... http://bit.ly/lZ7CBT #drug
Cimzia (Certolizumab Pegol) Shows Rapid Relief From Rheumatoid Arthritis Symptoms
disabled-world.com — “Adult Rheumatoid Arthritis patients treated with Cimzia that achieved early responses were found to have an increased chance of achieving longer-term outcomes” View full resource at disabled-world.com
Most Recently Shared on May 12, 2011 at 3:34 pm By:
Disabled World Health Advocate and Health News
Cimzia (Certolizumab Pegol) Shows Rapid Relief From Rheumatoid Arthritis Symptoms http://ff.im/-DehjB
Cimzia (certolizumab pegol) Data Showed Broad and Rapid Relief From Burden of Symptoms In Rheumatoid Arthritis Patients - Drugs.com MedNews
drugs.com — “Rapid, sustained and clinically meaningful improvement in wide-ranging patient-reported outcomes (PROs), including pain and quality of life, were seen in patien” View full resource at drugs.com
Most Recently Shared on May 10, 2011 at 5:13 pm By:
Drugs and Devices OW OW Health
Cimzia (certolizumab pegol) Data Showed Broad and Rapid Relief From Burden of Symptoms In Rheumatoid Arthr... http://bit.ly/jPPNrh #drug
Advertisement
